Malik Fady Ibraham, EVP of Research and Development at Cytokinetics Inc. ($CYTK), sold shares on the open market 21 times over the past year, totaling $2.2 million. His most recent sale occurred on March 9, 2026. These sales rank him 3,340th among 11,678 insiders by total value sold, below the average of $8.6 million per insider and 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 7636 | $62.15 | 158,299.0000 | 122,264,929 | 4.60% | 0.01% |
| March 17, 2026 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4397 | $62.15 | 153,902.0000 | 122,264,929 | 2.78% | 0.00% |
| March 15, 2026 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | A | Common Stock | 27306 | $0.00 | 165,935.0000 | 122,264,929 | 19.70% | 0.02% |
| March 15, 2026 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | A | Incentive Stock Option (Right to Buy) | 1665 | $0.00 | 1,665.0000 | 122,264,929 | 9999.99% | 0.00% |
| March 15, 2026 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | A | Non-Qualified Stock Option (Right to Buy) | 39527 | $0.00 | 39,527.0000 | 122,264,929 | 9999.99% | 0.03% |
| March 9, 2026 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2907 | $60.72 | 138,629.0000 | 122,264,929 | 2.05% | 0.00% |
| Dec. 22, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | F | Common Stock | 1016 | $62.72 | 141,536.0000 | 122,264,929 | 0.71% | 0.00% |
| Dec. 22, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | A | Common Stock | 2000 | $0.00 | 142,552.0000 | 122,264,929 | 1.42% | 0.00% |
| Dec. 22, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | A | Common Stock | 2000 | $0.00 | 140,552.0000 | 122,264,929 | 1.44% | 0.00% |
| Dec. 16, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Incentive Stock Option (Right to Buy) | 2200 | $0.00 | 0.0000 | 122,264,929 | 100.00% | 0.00% |
| Dec. 16, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2200 | $61.24 | 138,552.0000 | 122,264,929 | 1.56% | 0.00% |
| Dec. 16, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2200 | $10.60 | 140,752.0000 | 122,264,929 | 1.59% | 0.00% |
| Dec. 3, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | F | Common Stock | 2058 | $65.02 | 138,552.0000 | 122,264,929 | 1.46% | 0.00% |
| Dec. 2, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Incentive Stock Option (Right to Buy) | 2200 | $0.00 | 2,200.0000 | 122,264,929 | 50.00% | 0.00% |
| Dec. 2, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2200 | $10.60 | 142,810.0000 | 122,264,929 | 1.56% | 0.00% |
| Dec. 2, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2200 | $63.89 | 140,610.0000 | 122,264,929 | 1.54% | 0.00% |
| Nov. 18, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Incentive Stock Option (Right to Buy) | 2200 | $0.00 | 4,400.0000 | 122,264,929 | 33.33% | 0.00% |
| Nov. 18, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2200 | $66.45 | 140,610.0000 | 122,264,929 | 1.54% | 0.00% |
| Nov. 18, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2200 | $10.60 | 142,810.0000 | 122,264,929 | 1.56% | 0.00% |
| Nov. 4, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2295 | $10.60 | 142,905.0000 | 122,264,929 | 1.63% | 0.00% |
| Nov. 4, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Incentive Stock Option (Right to Buy) | 2295 | $0.00 | 6,600.0000 | 122,264,929 | 25.80% | 0.00% |
| Nov. 4, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2295 | $59.55 | 140,610.0000 | 122,264,929 | 1.61% | 0.00% |
| Oct. 21, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2105 | $0.00 | 1,000.0000 | 118,410,689 | 67.79% | 0.00% |
| Oct. 21, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2105 | $10.60 | 142,715.0000 | 118,410,689 | 1.50% | 0.00% |
| Oct. 21, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2105 | $58.22 | 140,610.0000 | 118,410,689 | 1.47% | 0.00% |
| Oct. 7, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $60.56 | 140,610.0000 | 118,410,689 | 1.40% | 0.00% |
| Oct. 7, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 3,105.0000 | 118,410,689 | 39.18% | 0.00% |
| Oct. 7, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,610.0000 | 118,410,689 | 1.42% | 0.00% |
| Sept. 23, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,610.0000 | 118,410,689 | 1.42% | 0.00% |
| Sept. 23, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 5,105.0000 | 118,410,689 | 28.15% | 0.00% |
| Sept. 23, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $49.28 | 140,610.0000 | 118,410,689 | 1.40% | 0.00% |
| Sept. 9, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $51.29 | 140,610.0000 | 118,410,689 | 1.40% | 0.00% |
| Sept. 9, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 7,105.0000 | 118,410,689 | 21.97% | 0.00% |
| Sept. 9, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,610.0000 | 118,410,689 | 1.42% | 0.00% |
| Aug. 19, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 9,105.0000 | 118,410,689 | 18.01% | 0.00% |
| Aug. 19, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,610.0000 | 118,410,689 | 1.42% | 0.00% |
| Aug. 19, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $38.31 | 140,610.0000 | 118,410,689 | 1.40% | 0.00% |
| Aug. 5, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $36.34 | 140,610.0000 | 118,410,689 | 1.40% | 0.00% |
| Aug. 5, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 11,105.0000 | 118,410,689 | 15.26% | 0.00% |
| Aug. 5, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,610.0000 | 118,410,689 | 1.42% | 0.00% |
| July 22, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 13,105.0000 | 118,410,689 | 13.24% | 0.00% |
| July 22, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,610.0000 | 118,410,689 | 1.42% | 0.00% |
| July 22, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $37.47 | 140,610.0000 | 118,410,689 | 1.40% | 0.00% |
| June 18, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Malik Fady Ibraham | Not found | A | Common Stock | 30000 | $0.00 | 30,000.0000 | 94,807,773 | 9999.99% | 0.03% |
| July 8, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $33.76 | 140,610.0000 | 118,410,689 | 1.40% | 0.00% |
| July 8, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 15,105.0000 | 118,410,689 | 11.69% | 0.00% |
| July 8, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,610.0000 | 118,410,689 | 1.42% | 0.00% |
| June 17, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $32.91 | 140,610.0000 | 118,410,689 | 1.40% | 0.00% |
| June 17, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 17,105.0000 | 118,410,689 | 10.47% | 0.00% |
| June 17, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,610.0000 | 118,410,689 | 1.42% | 0.00% |
| June 3, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $31.88 | 140,610.0000 | 118,410,689 | 1.40% | 0.00% |
| June 3, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 19,105.0000 | 118,410,689 | 9.48% | 0.00% |
| June 3, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,610.0000 | 118,410,689 | 1.42% | 0.00% |
| May 20, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 21,105.0000 | 118,410,689 | 8.66% | 0.00% |
| May 20, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,255.0000 | 118,410,689 | 1.43% | 0.00% |
| May 20, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $31.98 | 140,255.0000 | 118,410,689 | 1.41% | 0.00% |
| May 6, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $35.01 | 140,255.0000 | 118,410,689 | 1.41% | 0.00% |
| May 6, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,255.0000 | 118,410,689 | 1.43% | 0.00% |
| May 6, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 23,105.0000 | 118,410,689 | 7.97% | 0.00% |
| April 22, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 25,105.0000 | 118,410,689 | 7.38% | 0.00% |
| April 22, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,255.0000 | 118,410,689 | 1.43% | 0.00% |
| April 22, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $38.11 | 140,255.0000 | 118,410,689 | 1.41% | 0.00% |
| April 8, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 27,105.0000 | 118,410,689 | 6.87% | 0.00% |
| April 8, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $36.18 | 140,255.0000 | 118,410,689 | 1.41% | 0.00% |
| April 8, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,255.0000 | 118,410,689 | 1.43% | 0.00% |
| March 19, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | G | Common Stock | 200 | $0.00 | 140,255.0000 | 118,410,689 | 0.14% | 0.00% |
| March 18, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $43.58 | 140,455.0000 | 118,410,689 | 1.40% | 0.00% |
| March 18, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,455.0000 | 118,410,689 | 1.42% | 0.00% |
| March 14, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | A | Non-Qualified Stock Option (Right to Buy) | 58465 | $0.00 | 58,465.0000 | 118,410,689 | 9999.99% | 0.05% |
| March 14, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | A | Incentive Stock Option (Right to Buy) | 2293 | $0.00 | 2,293.0000 | 118,410,689 | 9999.99% | 0.00% |
| March 14, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | A | Common Stock | 39450 | $0.00 | 144,844.0000 | 118,410,689 | 37.43% | 0.03% |
| March 18, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 29,105.0000 | 118,410,689 | 6.43% | 0.00% |
| March 17, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4389 | $44.38 | 101,005.0000 | 118,410,689 | 4.16% | 0.00% |
| March 6, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 8228 | $43.27 | 105,394.0000 | 118,410,689 | 7.24% | 0.01% |
| March 3, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2449 | $42.88 | 113,622.0000 | 118,410,689 | 2.11% | 0.00% |
| March 4, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 31,105.0000 | 118,410,689 | 6.04% | 0.00% |
| March 4, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 118,071.0000 | 118,410,689 | 1.72% | 0.00% |
| March 4, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $42.50 | 116,071.0000 | 118,410,689 | 1.69% | 0.00% |
| Feb. 18, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $45.98 | 116,071.0000 | 0 | 1.69% | 0.00% |
| Feb. 18, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 118,071.0000 | 0 | 1.72% | 0.00% |
| Feb. 18, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 33,105.0000 | 0 | 5.70% | 0.00% |
| Feb. 4, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 35,105.0000 | 0 | 5.39% | 0.00% |
| Feb. 4, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 118,071.0000 | 0 | 1.72% | 0.00% |
| Feb. 4, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $48.06 | 116,071.0000 | 0 | 1.69% | 0.00% |
| Jan. 21, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 37,105.0000 | 0 | 5.11% | 0.00% |
| Jan. 21, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $45.92 | 116,071.0000 | 0 | 1.69% | 0.00% |
| Jan. 21, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 118,071.0000 | 0 | 1.72% | 0.00% |
| Jan. 7, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 118,071.0000 | 0 | 1.72% | 0.00% |
| Jan. 7, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $49.32 | 116,071.0000 | 0 | 1.69% | 0.00% |
| Jan. 7, 2025 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 39,105.0000 | 0 | 4.87% | 0.00% |
| Dec. 10, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 10, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 123,371.0000 | 0 | 4.49% | 0.00% |
| Dec. 10, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $50.65 | 116,071.0000 | 0 | 1.69% | 0.00% |
| Dec. 10, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $50.63 | 118,071.0000 | 0 | 4.30% | 0.00% |
| Dec. 3, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | A | Common Stock | 4000 | $0.00 | 118,071.0000 | 0 | 3.51% | 0.00% |
| Dec. 3, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | A | Common Stock | 4000 | $0.00 | 116,099.0000 | 0 | 3.57% | 0.00% |
| Dec. 3, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | F | Common Stock | 2028 | $51.51 | 114,071.0000 | 0 | 1.75% | 0.00% |
| Nov. 26, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 5,300.0000 | 0 | 50.00% | 0.00% |
| Nov. 26, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 119,178.0000 | 0 | 4.65% | 0.00% |
| Nov. 26, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $50.17 | 113,878.0000 | 0 | 4.45% | 0.00% |
| Nov. 26, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $50.14 | 111,878.0000 | 0 | 1.76% | 0.00% |
| Nov. 12, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 1042 | $58.48 | 113,878.0000 | 0 | 0.91% | 0.00% |
| Nov. 12, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 120,220.0000 | 0 | 4.61% | 0.00% |
| Nov. 12, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $58.48 | 114,920.0000 | 0 | 4.41% | 0.00% |
| Nov. 12, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 10,600.0000 | 0 | 33.33% | 0.00% |
| Oct. 30, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $51.93 | 114,920.0000 | 0 | 1.71% | 0.00% |
| Oct. 30, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 122,220.0000 | 0 | 4.53% | 0.00% |
| Oct. 30, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $51.90 | 116,920.0000 | 0 | 4.34% | 0.00% |
| Oct. 30, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 15,900.0000 | 0 | 25.00% | 0.00% |
| Oct. 15, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $54.20 | 116,920.0000 | 0 | 1.68% | 0.00% |
| Oct. 15, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 124,220.0000 | 0 | 4.46% | 0.00% |
| Oct. 15, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $54.18 | 118,920.0000 | 0 | 4.27% | 0.00% |
| Oct. 15, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 21,200.0000 | 0 | 20.00% | 0.00% |
| Oct. 1, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 26,500.0000 | 0 | 16.67% | 0.00% |
| Oct. 1, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $52.09 | 118,920.0000 | 0 | 4.27% | 0.00% |
| Oct. 1, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 124,220.0000 | 0 | 4.46% | 0.00% |
| Oct. 1, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $52.11 | 118,920.0000 | 0 | 1.65% | 0.00% |
| Sept. 17, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 31,800.0000 | 0 | 14.29% | 0.00% |
| Sept. 17, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $56.77 | 122,920.0000 | 0 | 4.13% | 0.00% |
| Sept. 17, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 128,220.0000 | 0 | 4.31% | 0.00% |
| Sept. 17, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $56.76 | 120,920.0000 | 0 | 1.63% | 0.00% |
| Sept. 3, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $57.02 | 122,920.0000 | 0 | 4.13% | 0.00% |
| Sept. 3, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 128,220.0000 | 0 | 4.31% | 0.00% |
| Sept. 3, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2084 | $56.99 | 122,920.0000 | 0 | 1.67% | 0.00% |
| Sept. 3, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 37,100.0000 | 0 | 12.50% | 0.00% |
| Aug. 20, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 130,304.0000 | 0 | 4.24% | 0.00% |
| Aug. 20, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 42,400.0000 | 0 | 11.11% | 0.00% |
| Aug. 20, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $56.23 | 125,004.0000 | 0 | 1.57% | 0.00% |
| Aug. 20, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $56.26 | 125,004.0000 | 0 | 4.07% | 0.00% |
| Aug. 6, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $53.74 | 121,704.0000 | 0 | 1.62% | 0.00% |
| Aug. 7, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 47,700.0000 | 0 | 10.00% | 0.00% |
| Aug. 6, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $53.70 | 123,704.0000 | 0 | 4.11% | 0.00% |
| Aug. 7, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 127,004.0000 | 0 | 4.35% | 0.00% |
| July 23, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $57.02 | 129,004.0000 | 0 | 3.95% | 0.00% |
| July 23, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 134,304.0000 | 0 | 4.11% | 0.00% |
| July 23, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $57.02 | 129,004.0000 | 0 | 1.53% | 0.00% |
| July 23, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 53,000.0000 | 0 | 9.09% | 0.00% |
| July 9, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 58,300.0000 | 0 | 8.33% | 0.00% |
| July 9, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 138,304.0000 | 0 | 3.98% | 0.00% |
| July 9, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $55.91 | 133,004.0000 | 0 | 3.83% | 0.00% |
| July 9, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $55.89 | 131,004.0000 | 0 | 1.50% | 0.00% |
| June 25, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $53.74 | 133,004.0000 | 0 | 1.48% | 0.00% |
| June 25, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 138,304.0000 | 0 | 3.98% | 0.00% |
| June 25, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 63,600.0000 | 0 | 7.69% | 0.00% |
| June 25, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $53.71 | 133,004.0000 | 0 | 3.83% | 0.00% |
| June 13, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Malik Fady Ibraham | Not found | A | Stock Option (Right to Buy) | 23944 | $0.00 | 23,944.0000 | 84,009,004 | 9999.99% | 0.03% |
| June 11, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2366 | $53.03 | 135,004.0000 | 0 | 1.72% | 0.00% |
| June 11, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5422 | $0.00 | 68,900.0000 | 0 | 7.30% | 0.00% |
| June 11, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5422 | $7.96 | 142,792.0000 | 0 | 3.95% | 0.00% |
| June 11, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5422 | $53.05 | 137,370.0000 | 0 | 3.80% | 0.00% |
| May 7, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 1361 | $65.11 | 137,056.0000 | 0 | 0.98% | 0.00% |
| May 7, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 14186 | $6.67 | 152,603.0000 | 0 | 10.25% | 0.00% |
| May 7, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 14186 | $65.11 | 138,417.0000 | 0 | 9.30% | 0.00% |
| May 7, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Incentive Stock Option (Right to Buy) | 14186 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 12, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | G | Common Stock | 150 | $0.00 | 138,417.0000 | 0 | 0.11% | 0.00% |
| April 9, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 28605 | $6.67 | 171,172.0000 | 0 | 20.06% | 0.00% |
| April 9, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 28605 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 9, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4000 | $74.32 | 138,567.0000 | 0 | 2.81% | 0.00% |
| April 9, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 28605 | $74.31 | 142,567.0000 | 0 | 16.71% | 0.00% |
| March 14, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | A | Incentive Stock Option (Right to Buy) | 1541 | $0.00 | 1,541.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | A | Common Stock | 21333 | $0.00 | 142,567.0000 | 0 | 17.60% | 0.00% |
| March 14, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | A | Non-Qualified Stock Option (Right to Buy) | 23103 | $0.00 | 23,103.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | F | Common Stock | 8109 | $66.88 | 121,234.0000 | 0 | 6.27% | 0.00% |
| March 4, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | F | Common Stock | 9630 | $67.68 | 133,343.0000 | 0 | 6.74% | 0.00% |
| March 5, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 28604 | $0.00 | 28,605.0000 | 0 | 50.00% | 0.00% |
| March 5, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 28604 | $6.67 | 167,577.0000 | 0 | 20.58% | 0.00% |
| March 5, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4000 | $67.53 | 138,973.0000 | 0 | 2.80% | 0.00% |
| March 5, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 28604 | $67.56 | 138,973.0000 | 0 | 17.07% | 0.00% |
| Feb. 6, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 28605 | $6.67 | 175,578.0000 | 0 | 19.46% | 0.00% |
| Feb. 6, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 28605 | $0.00 | 57,209.0000 | 0 | 33.33% | 0.00% |
| Feb. 6, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4000 | $79.28 | 142,973.0000 | 0 | 2.72% | 0.00% |
| Feb. 6, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 28605 | $79.30 | 146,973.0000 | 0 | 16.29% | 0.00% |
| Jan. 4, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 11678 | $86.98 | 150,973.0000 | 0 | 7.18% | 0.00% |
| Jan. 4, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4000 | $86.99 | 146,973.0000 | 0 | 2.65% | 0.00% |
| Jan. 4, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Incentive Stock Option (Right to Buy) | 11678 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 4, 2024 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 11678 | $7.96 | 162,651.0000 | 0 | 7.74% | 0.00% |
| Nov. 9, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2500 | $35.40 | 150,664.0000 | 0 | 1.63% | 0.00% |
| Oct. 12, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2500 | $35.89 | 153,164.0000 | 0 | 1.61% | 0.00% |
| Sept. 14, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2500 | $34.86 | 155,664.0000 | 0 | 1.58% | 0.00% |
| Aug. 10, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2500 | $31.70 | 158,164.0000 | 0 | 1.56% | 0.00% |
| July 13, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2500 | $35.37 | 160,664.0000 | 0 | 1.53% | 0.00% |
| June 8, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2500 | $38.07 | 163,164.0000 | 0 | 1.51% | 0.00% |
| May 11, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 1787 | $39.50 | 165,396.0000 | 0 | 1.07% | 0.00% |
| May 3, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 7000 | $7.96 | 174,183.0000 | 0 | 4.19% | 0.00% |
| May 3, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 7000 | $40.00 | 167,183.0000 | 0 | 4.02% | 0.00% |
| May 3, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 7000 | $0.00 | 74,322.0000 | 0 | 8.61% | 0.00% |
| April 13, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4000 | $34.21 | 167,183.0000 | 0 | 2.34% | 0.00% |
| March 9, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4000 | $39.10 | 171,183.0000 | 0 | 2.28% | 0.00% |
| March 6, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | F | Common Stock | 4958 | $39.13 | 135,183.0000 | 0 | 3.54% | 0.00% |
| March 6, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | A | Common Stock | 40000 | $0.00 | 175,183.0000 | 0 | 29.59% | 0.00% |
| March 6, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | A | Incentive Stock Option (Right to Buy) | 2555 | $0.00 | 2,555.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | A | Non-Qualified Stock Option (Right to Buy) | 77445 | $0.00 | 77,445.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | F | Common Stock | 10785 | $39.60 | 140,141.0000 | 0 | 7.15% | 0.00% |
| Feb. 16, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | F | Common Stock | 1513 | $44.13 | 150,926.0000 | 0 | 0.99% | 0.00% |
| Feb. 10, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | G | Common Stock | 150 | $0.00 | 152,439.0000 | 0 | 0.10% | 0.00% |
| Feb. 9, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 7000 | $7.96 | 163,589.0000 | 0 | 4.47% | 0.00% |
| Feb. 9, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4000 | $43.73 | 152,589.0000 | 0 | 2.55% | 0.00% |
| Feb. 9, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 7000 | $43.74 | 156,589.0000 | 0 | 4.28% | 0.00% |
| Feb. 9, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 7000 | $0.00 | 81,322.0000 | 0 | 7.93% | 0.00% |
| Jan. 12, 2023 | CYTOKINETICS INC | $CYTK | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4000 | $40.47 | 156,589.0000 | 0 | 2.49% | 0.00% |